| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/30/2008 | EP1507804B1 Active carbohydrate containing protecting reagents for chemical modifications, their production and use |
| 01/30/2008 | EP0972063B1 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof |
| 01/30/2008 | EP0941125B1 Methods for regulating angiogenesis |
| 01/30/2008 | EP0820473B2 Biodegradable polyacetal polymers and formation and use |
| 01/30/2008 | CN101115770A Pyy agonists and uses thereof |
| 01/30/2008 | CN101115769A Interferon-alpha polypeptides and conjugates |
| 01/30/2008 | CN101115512A Improved device for application of medicaments, manufacturing method therefor, and method of treatment |
| 01/30/2008 | CN101115472A Molecules enhancing dermal delivery of influenza vaccines |
| 01/30/2008 | CN101115469A Quick disintegration tablet and method of producing the same |
| 01/30/2008 | CN101112620A Cisplatin-hydroxyapatite -chitose sustained-release microsphere and uses thereof |
| 01/30/2008 | CN101112541A Entecavir medicinal composition and uses thereof |
| 01/30/2008 | CN101112511A Chinese traditional medicine gelling agent for treating laryngopharynx gall |
| 01/30/2008 | CN101112465A Maoyan' berry effervescence tablets and production process thereof |
| 01/30/2008 | CN101112438A Chinese traditional medicine tablets for relieving cough and method for preparing the same |
| 01/30/2008 | CN101112437A Chinese traditional medicine dripping pills for relieving cough and method for preparing the same |
| 01/30/2008 | CN101112417A Rheum defervescence liniment and method for preparing the same |
| 01/30/2008 | CN101112405A Drug for curing coronary disease and method for preparing the same |
| 01/30/2008 | CN101112386A Smectite middle gut positioning releasing pellet and method for preparing the same |
| 01/30/2008 | CN101112383A Compositions for treating of cough |
| 01/30/2008 | CN101112379A Azithromycin orally disintegrating tablets and method for preparing the same |
| 01/30/2008 | CN101112374A Camptothecinum-layered thermometal hydroxide nanometer complexes and method for preparing the same |
| 01/30/2008 | CN101112373A Methods of administering epothilone analogs for the treatment of cancer |
| 01/30/2008 | CN101112366A Skin-protecting wiping slice |
| 01/30/2008 | CN101112365A Method for preparing Nabothí»s cyst containing manifold cell growth factors and use thereof |
| 01/30/2008 | CN101112364A Hepadestal preparations and method for preparing the same |
| 01/30/2008 | CN101112362A Dispersion tablets for treating and preventing upper respiratory tract infection |
| 01/30/2008 | CN101112361A Magnetic nanometer particulate of liposoluble photosensitizer and method for preparing the same |
| 01/30/2008 | CN101112360A Allicin fatty milk injection and preparation technics thereof |
| 01/30/2008 | CN100365117C Pegylated and diglycosylated erythropoietin |
| 01/30/2008 | CN100365043C Synthesis of ABA polypeptide -b- polytetrahydrofuran-b-polypeptide triblock copolymer |
| 01/30/2008 | CN100365041C Polyoxyethylene ligand containing coupler and its synthesis process |
| 01/30/2008 | CN100365024C Linear cyclodextrin copolymers |
| 01/30/2008 | CN100365021C Nucleic protein 'Shoca'-a component of wnt signal transmission channel |
| 01/30/2008 | CN100364552C Load type super-fine copper-powder copper-complementary agent, its prepn. method and use |
| 01/30/2008 | CN100364551C Load type super-fine zinc powder zinc-complementary agent, its prepn. method and use |
| 01/30/2008 | CN100364549C Load type super-fine iron powder iron-complementary agent, its prepn. method and use |
| 01/30/2008 | CN100364548C Iron replenisher with control released iron and its preparing method and use |
| 01/30/2008 | CN100364547C Load type molecular iodine complementary agent, and its prepn. method and use |
| 01/30/2008 | CN100364544C Gelatin micro-particles carried with dichloromethylene diphosphonate, and its prepn. method |
| 01/30/2008 | CN100364528C Compound amino acid vitamin dispersion tablet and its preparation method |
| 01/30/2008 | CN100364525C Docetaxel liposome containing chitosan derivative, lyophiled preparation and preparation method thereof |
| 01/30/2008 | CN100364517C Water-soluble medicine degradable polymer microcapsule injecta and preparing method |
| 01/30/2008 | CN100364515C Drug form with different shapes of cores and shells |
| 01/30/2008 | CN100364514C Biodegradable ocular implant |
| 01/30/2008 | CN100364501C Pharmaceutical composition of topiramate |
| 01/30/2008 | CN100364499C Zinc-containing sustained-release composition, its preparation, and method for producing the same |
| 01/29/2008 | US7323594 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried |
| 01/29/2008 | US7323543 Insulin, insulin-related peptide, and sensitizer; side effect reduction |
| 01/29/2008 | US7323507 Stable dispersion concentrate consisting of a copolymer of acryloyldimethyltauric acid and cyclic carboxamide and an oil, emulsifier, or oil/emulsifier phase for cosmetic, pharmaceutical and dermatological compositions, and methods for preparation thereof |
| 01/29/2008 | US7323463 Combination of brimonidine and timolol for topical ophthalmic use |
| 01/29/2008 | US7323195 Enteric formulations of proanthocyanidin polymer antidiarrheal compositions |
| 01/29/2008 | US7323183 Vaccine compositions including chitosan for intranasal administration and use thereof |
| 01/29/2008 | US7323182 Oil in water emulsions containing saponins |
| 01/29/2008 | US7323176 Immuno-modulating antitumor activities of ganoderma lucidum (reishi) polysaccharides |
| 01/29/2008 | US7323169 Sustained release formulations |
| 01/29/2008 | US7323167 Bonded to polyethylene glycol through a linking group, wherein the arginine deiminase is derived from Streptococcus, Borrelia, Giardia, Clostridium, Enterococcus, Lactobacillus, or Bacillus; improved tumoricidal activity; anticarcinogenic, antitumor, antimetastasis agents; melanoma |
| 01/29/2008 | US7323164 Can be administered in conjunction with radiation or chemotherapeutic agents. |
| 01/29/2008 | US7323163 Film-forming compositions and methods |
| 01/29/2008 | CA2471775C Targeted cytotoxic anthracycline analogs |
| 01/29/2008 | CA2451851C Use of pigment such as e.g. titanium dioxide for obtaining a special optical effect on oral medicament or food |
| 01/29/2008 | CA2438188C Modulated release particles for aerosol delivery |
| 01/29/2008 | CA2436540C Pharmaceutical compositions based on anticholinergics and corticosteroids |
| 01/29/2008 | CA2398485C Azalide antibiotic compositions |
| 01/29/2008 | CA2342634C Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative |
| 01/29/2008 | CA2315696C Pharmaceutical composition for oral administration |
| 01/29/2008 | CA2311128C Composition with azelaic acid |
| 01/29/2008 | CA2285985C A method for preparing aqueous liposomal compositions comprising an active ingredient which is highly insoluble in water |
| 01/29/2008 | CA2267651C Method of stimulating growth of melanocyte precursor cells with stem cell factor polypeptide |
| 01/29/2008 | CA2251982C Ophthalmic compound with extended dwell time on the eye |
| 01/29/2008 | CA2232989C 1,2,4-benzotriazine oxides formulations |
| 01/29/2008 | CA2172886C Maltitol composition and process for preparing the same |
| 01/29/2008 | CA2149776C Use of methioninase as an antitumor agent in anti-methionine chemotherapy |
| 01/24/2008 | WO2008011545A1 Dendrimer-drug conjugates |
| 01/24/2008 | WO2008011087A2 Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease |
| 01/24/2008 | WO2008010524A1 Process for producing spherical elementary granule containing readily water-soluble drug |
| 01/24/2008 | WO2008010463A1 Polymer conjugate of combretastatin |
| 01/24/2008 | WO2008010403A1 Method for preventing coloration of catechins and dentifrice composition |
| 01/24/2008 | WO2008010362A1 Powder of vitamin e/proline complex and method of producing the same |
| 01/24/2008 | WO2008010341A1 Physiologically active polypeptide, polymer micelle having protein enclosed therein, and process for production of the polymer micelle |
| 01/24/2008 | WO2008010223A2 Conjugates comprising a psychotropic drug or a gaba agonist and an organic acid and their use in treating pain and other cns disorders |
| 01/24/2008 | WO2008010222A2 Conjugates comprising a gaba- or glycine compound, pharmaceutical compositions and combinations thereof and their use in treating cns disorders |
| 01/24/2008 | WO2008009689A1 Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same |
| 01/24/2008 | WO2008009444A1 Use of ethanol for stabilizing a single-vial liquid formulation of a radiolabeled peptide |
| 01/24/2008 | WO2008009172A1 Controlled release composition and preparation thereof |
| 01/24/2008 | WO2007137760A3 Dimeric molecular complexes |
| 01/24/2008 | WO2007130848A3 Compositions comprising biomembrane sealing agent for treatment of neuronal injury, and methods of use |
| 01/24/2008 | WO2007113885A3 Solid oral compositions based on s-adenosyl methionine and/or nadh and process for obtaining them |
| 01/24/2008 | WO2007049265A3 Anti mineralocorticoid therapy of infection |
| 01/24/2008 | WO2007037849A3 Compositions and methods for the intraocular transport of therapeutic agents |
| 01/24/2008 | WO2007022493A3 Ligand conjugates of vinca alkaloids, analogs, and derivatives |
| 01/24/2008 | WO2005120578A3 Biodegradable drug-polymer delivery system |
| 01/24/2008 | WO2004081188A3 Non-toxic membrane-translocating peptides |
| 01/24/2008 | WO2004016225A8 Compositions and methods for the diagnosis and treatment of tumor |
| 01/24/2008 | US20080021106 Cellular uptake of bioactive agents |
| 01/24/2008 | US20080021103 Mucoadhesive composition |
| 01/24/2008 | US20080021015 Use as medicine of a compound restoring active principles in vivo |
| 01/24/2008 | US20080021005 Pegylated Ion Channel Modulating Compounds |
| 01/24/2008 | US20080020990 Oligo Double-Stranded Rna Inhibiting the Expression of Bcl-2 and Pharmaceutical Composition Containing the Same |
| 01/24/2008 | US20080020073 Use of oligosaccharides to stimulate beta-endorphin production |
| 01/24/2008 | US20080020063 Anti-angiogenic compositions and methods of use |